Impact of Presenting Symptoms on Treatment Time and Outcomes in Acute Ischemic Stroke
- Sponsor
- Assiut University
- Study ID
- NCT07750847
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This observational study aims to understand how the specific symptoms a person experiences at the start of an acute ischemic stroke affect how quickly they receive treatment and how well they recover. In stroke care, rapid treatment is critical because delayed intervention can lead to more severe disability or death. Patients who experience "high urgency" or classic stroke symptoms, such as sudden paralysis, severe facial drooping, or loss of speech, tend to arrive at the emergency room very quickly because these signs are easily recognized by bystanders. In contrast, patients who experience "low urgency" or vague symptoms, such as dizziness, numbness, visual changes, or a new-onset headache, often delay seeking medical care. Because these vague symptoms can mimic other medical conditions, they can lead to delayed diagnosis and longer waiting times for specific stroke treatments. The researchers will observe 120 adult patients admitted for a first-ever acute ischemic stroke. Participants will be categorized into two groups based on whether their initial stroke symptoms were highly urgent or vague. The study will track and compare both groups to evaluate: * The time it takes for patients to arrive at the hospital and receive intervention therapies. * The patients' level of physical disability and independence in daily activities. * The patients' cognitive function. * The total length of the hospital stay, complication rates, and overall survival. Participants will be monitored from the time of their hospital admission through their discharge. To measure long-term recovery and functional outcomes, patients will also complete follow-up assessments at two weeks, one month, two months, and three months after leaving the hospital.
Key Dates
- First listed
- Aug 6, 2026
- Start date
- Sep 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Sep 30, 2027
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 120 participants (estimated)
Arms
- Arm: High Urgency SymptomsPatients with a first-ever acute ischemic stroke (AIS) presenting with "high urgency" classic symptoms, such as sudden hemiplegia/hemiparesis, severe facial droop, or profound aphasia. These patients are admitted for acute stroke management and will receive specific stroke interventions (e.g., rTPA or mechanical thrombectomy) if they meet the eligibility criteria.
- Arm: Low Urgency or Vague SymptomsPatients with a first-ever acute ischemic stroke (AIS) presenting with "low urgency" or vague symptoms, which may include sensory deficits, vestibular symptoms, visual disturbances, new-onset headache, wake-up strokes, or altered mental status. These patients are admitted for conventional ward care, undergoing a standard medical workup and generalized nursing management.
Primary Outcome Measure
Functional Dependence Assessed by the Modified Rankin Scale (mRS) [ Time Frame: 2 weeks after discharge ]
Find similar trials
Related Studies
- Evaluation of an Advanced Lower Extremity NeuroprosthesesRecruiting · Case Western Reserve University · Cleveland, Ohio
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- A Closed Loop Neural Activity Triggered Stroke Rehabilitation DeviceRecruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Human-Machine System for the H2 Lower Limb ExoskeletonRecruiting · University of Houston · Houston, Texas